PROTECTIVE EFFECT OF SYNTHETIC ANTIOXIDANTS AND ETHANOLIC EXTRACT OF BACOPA MONNIERI AGAINST LEAD TOXICITY INDUCED METABOLIC DYSFUNCTIONS IN MICE BRAIN AND LIVER HOMOGENATES: AN IN VITRO APPROACH
Objective: The main objective of the present study was to investigate the ameliorative potential of synthetic antioxidants mixture comprising N-acetyl cysteine, ascorbic acid, tocopheryl acetate, and thiamine as micronutrient combinational therapy and ethanolic extract of Bacopa monnieri as herbal antioxidant therapy approach against lead toxicity-induced metabolic dysfunctions in vitro.
Methods: Experimental study involved in vitro exposure of mice brain and liver homogenates to different doses (100 μM, 250 μM, and 500 μM) of lead acetate. The study also involved coadministration of high-dose lead acetate (500 μM) and specific dosage of synthetic antioxidants or ethanolic extract of B. monnieri separately to homogenate cultures. Alterations in metabolic parameters of protein levels and lipid peroxidation were analyzed for evaluating the protective effect of synthetic antioxidants and B. monnieri against lead intoxication.
Results: Results revealed dose-dependent statistically significant (p<0.001) reduction in protein levels and elevation in lipid peroxidation in lead acetate exposed mice brain and liver homogenates as compared to their respective control groups. Coadministration of lead acetate and synthetic antioxidants mixture or B. monnieri in the brain and liver homogenates conferred protection and manifested maintenance of studied biochemical parameters nearest to control groups. Ameliorative efficacy of B. monnieri against lead-induced neurotoxicity and hepatotoxicity was found to be more pronounced than that of a mixture of synthetic antioxidants.
Conclusion: Synthetic antioxidants mixture (N-acetyl cysteine, ascorbic acid, tocopheryl acetate, and thiamine) and B. monnieri exhibited remarkable therapeutic efficacy against lead toxicity-induced metabolic dysfunctions in mice brain and liver homogenates by virtue of their antioxidant, neuroprotective, and hepatoprotective abilities.
2. Garza A, Vega R, Soto E. Cellular mechanisms of lead neurotoxicity. Med Sci Monit 2006;12:57-65.
3. Gurer H, Ercal N. Can antioxidants be beneficial in the treatment of lead poisoning? Free Radic Biol Med 2000;29:927-45.
4. Paoliello MM, De Capitani EM. Environmental contamination and human exposure to lead in Brazil. Rev Environ Contam Toxicol 2005;184:59-96.
5. Chaurasia SS, Gupta P, Kar A, Maiti PK. Lead induced thyroid dysfunction and lipid peroxidation in the fish Clarias batrachus with special reference to hepatic type i-5’-monodeiodinase activity. Bull Environ Contam Toxicol 1996;56:649-54.
6. Adonaylo VN, Oteiza PI. Lead intoxication: Antioxidant defenses and oxidative damage in rat brain. Toxicology 1999;135:77-85.
7. Abu-taweel G. Curcumin attenuates lead acetate induced neurobehavioral and neurobiochemical dysfunction: A review. Int J Pharm Pharm Sci 2018;10:23-8.
8. Soltaninejad K, Kebriaeezadeh A, Minaiee B, Ostad SN, Hosseini R, Azizi E, et al. Biochemical and ultrastructural evidences for toxicity of lead through free radicals in rat brain. Hum Exp Toxicol 2003;22:417 23.
9. Lanphear BP, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations <10 microg/dL in US children and adolescents. Public Health Rep 2000;115:521-9.
10. Patra RC, Swarup D, Dwivedi SK. Antioxidant effects of alpha tocopherol, ascorbic acid and L-methionine on lead induced oxidative stress to the liver, kidney and brain in rats. Toxicology 2001;162:81-8.
11. Sivaprasad R, Nagaraj M, Varalakshmi P. Combined efficacies of lipoic acid and 2,3-dimercaptosuccinic acid against lead-induced lipid peroxidation in rat liver. J Nutr Biochem 2004;15:18-23.
12. Ronis MJ, Badger TM, Shema SJ, Roberson PK, Templer L, Ringer D, et al. Endocrine mechanisms underlying the growth effects of developmental lead exposure in the rat. J Toxicol Environ Health A 1998;54:101-20.
13. Canfield RL, Henderson CR Jr., Cory-Slechta DA, Cox C, Jusko TA, Lanphear BP, et al. Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter. N Engl J Med 2003;348:1517-26.
14. Koller K, Brown T, Spurgeon A, Levy L. Recent developments in low-level lead exposure and intellectual impairment in children. Environ Health Perspect 2004;112:987-94.
15. Mudipalli A. Lead hepatotoxicity and potential health effects. Indian J Med Res 2007;126:518-27.
16. Zmudzki J, Bratton GR, Womac C, Rowe L. Lead poisoning in cattle: Reassessment of minimum toxic oral dose. Bull Environ Contam Toxicol 1983;30:435-41.
17. Aziz FM, Maulood IM, Chawsheen MA. Effects of melatonin, Vitamin C and Vitamin E alone or in combination on lead-induced injury in liver and kidney organs of rats. IOSR J Pharm 2012;2:13-8.
18. Prabha P, Rajkumar J. Histological study on protective effect of aquatic weed Hydrilla verticillata against lead induced toxicity in fish. Int J Pharm Pharm Sci 2015;8:132-6.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
20. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
21. Sandhir R, Gill KD. Effect of lead on lipid peroxidation in liver of rats. Biol Trace Elem Res 1995;48:91-7.
22. Chiba M, Shinohara A, Matsushita K, Watanabe H, Inaba Y. Indices of lead-exposure in blood and urine of lead-exposed workers and concentrations of major and trace elements and activities of SOD, GSH-px and catalase in their blood. Tohoku J Exp Med 1996;178:49 62.
23. Halliwell B, Gutteridge JM. The definition and measurement of antioxidants in biological systems. Free Radic Biol Med 1995;18:125 6.
24. Esterbauer H. Lipid peroxidation products formation, Chemical properties and biological activities. In: Poli G, Cheesman KH, Dianzani MV, Slater TF. Free Radical in Liver Injury. Oxford, IRL Press Ltd.; 1986. p. 29-45.
25. Vallee BL, Ulmer DD. Biochemical effects of mercury, cadmium, and lead. Annu Rev Biochem 1972;41:91-128.
26. Shashi A, Thapar SP, Singh JP. Effects of fluoride administration on organs of gastrointestinal tract-an experimental study on rabbits-effects on tissue proteins. Fluoride 1987;20:183-8.
27. Shalan MG, Mostafa MS, Hassouna MM, El-Nabi SE, El-Refaie A. Amelioration of lead toxicity on rat liver with Vitamin C and silymarin supplements. Toxicology 2005;206:1-5.
28. Sajitha GR, Jose R, Andrews A, Ajantha KG, Augustine P, Augusti KT, et al. Garlic oil and Vitamin E prevent the adverse effects of lead acetate and ethanol separately as well as in combination in the drinking water of rats. Indian J Clin Biochem 2010;25:280-8.
29. Simons TJ. Lead-calcium interactions in cellular lead toxicity. Neurotoxicology 1993;14:77-85.
30. Needleman HL, Bellinger D. The health effects of low level exposure to lead. Annu Rev Public Health 1991;12:111-40.
31. El-Zayat EM, El-Ymany NA, Kamel ZH. Combined supplementation of zinc and vitamin C as protective agents against lead toxicity in growing male albino rats. Liver functions. J Egypt Ger Soc Zool 1996;20:115 39.
32. Sharma A, Sharma V, Kansal L. Amelioration of lead-induced hepatotoxicity by Allium sativum extracts in Swiss albino mice. Libyan J Med 2010;5:4621.
33. Sharma V, Sharma A, Kansal L. The effect of oral administration of Allium sativum extracts on lead nitrate induced toxicity in male mice. Food Chem Toxicol 2010;48:928-36.
34. Sharma S, Sharma V, Sharma SP. Therapeutic potential of hydromethanolic root extract of Withania somnifera on neurological parameters in Swiss albino mice subjected to lead nitrate. Int J Curr Pharm Res 2011;3:52-6.
35. Patrick L. Lead toxicity part II: The role of free radical damage and the use of antioxidants in the pathology and treatment of lead toxicity. Altern Med Rev 2006;11:114-27.
36. Halliwell B. Mechanisms involved in the generation of free radicals. Pathol Biol (Paris) 1996;44:6-13.
37. Kang JK, Sul D, Kang JK, Nam SY, Kim HJ, Lee E, et al. Effects of lead exposure on the expression of phospholipid hydroperoxidase glutathione peroxidase mRNA in the rat brain. Toxicol Sci 2004;82:228 36.
38. Caylak E, Aytekin M, Halifeoglu I. Antioxidant effects of methionine, alpha-lipoic acid, N-acetylcysteine and homocysteine on lead-induced oxidative stress to erythrocytes in rats. Exp Toxicol Pathol 2008;60:289 94.
39. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990;9:515-40.
40. Maiti PK, Kar A, Gupta P, Chaurasia SS. Loss of membrane integrity and inhibition of type-I iodothyronine 5’-monodeiodinase activity by fenvalerate in female mouse. Biochem Biophys Res Commun 1995;214:905-9.
41. Subramaniam S, Shyama S, Shyamaladevi CS. Protective effect of Vitamin E against CMF-induced damages in small intestinal brush border membrane of rats. Indian J Pharmacol 1994;26:213-7.
42. Marks DB, Marks AD, Smith CM. Basic medical biochemistry-A clinical approach. Enzyme, Chapter: 9, p. 99-128, Oxygen metabolism and oxygen Toxicity. Ch.21, p. 327-339 and Cholesterol metabolism and the blood lipoproteins, Chapter: 34, p. 525-544. Williams and Wilkins, A Wavery Company, Baltimore, Maryland, USA; 1996.
43. Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: Mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem 2001;1:529-39.
44. El-Sokkary GH, Abdel-Rahman GH, Kamel ES. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 2005;213:25-33.
45. Upsani CD, Bataraman R. Effect of Vitamin E, Vitamin C and spirulina on the levels of membrane bound enzymes and lipids in some organs of rats exposed to lead. Indian J Pharmacol 2003;33:185-91.
46. Mohammad IK, Mahdi AA, Raviraja A, Najmul I, Iqbal A, Thuppil V, et al. Oxidative stress in painters exposed to low lead levels. Arh Hig Rada Toksikol 2008;59:161-9.
47. Sandhir R, Julka D, Gill KD. Lipoperoxidative damage on lead exposure in rat brain and its implications on membrane bound enzymes. Pharmacol Toxicol 1994;74:66-71.
48. Ercal N, Treeratphan P, Lutz P, Hammond TC, Matthews RH. N-actylcysteine protects Chinese hamster ovary (CHO) cells from lead-induced oxidative stress. Toxicology 1996;108:57-64.
49. Gürer H, Ozgünes H, Neal R, Spitz DR, Erçal N. Antioxidant effects of N-acetylcysteine and succimer in red blood cells from lead-exposed rats. Toxicology 1998;128:181-9.
50. Villeda-Hernández J, Barroso-Moguel R, Méndez-Armenta M, Nava-Ruíz C, Huerta-Romero R, Ríos C, et al. Enhanced brain regional lipid peroxidation in developing rats exposed to low level lead acetate. Brain Res Bull 2001;55:247-51.
51. Upasani CD, Khera A, Balaraman R. Effect of lead with Vitamin E, C, or spirulina on malondialdehyde, conjugated dienes and hydroperoxides in rats. Indian J Exp Biol 2001;39:70-4.
52. Shukla PK, Khanna VK, Khan MY, Srimal RC. Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol 2003;22:653-8.
53. Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 2004;98:266-75.
54. Bennet C, Bettaiya R, Rajanna S, Baker L, Yallapragada PR, Brice JJ, et al. Region specific increase in the antioxidant enzymes and lipid peroxidation products in the brain of rats exposed to lead. Free Radic Res 2007;41:267-73.
55. Kansal L, Sharma V, Sharma A, Lodi S, Sharma SH. Protective role of Coriandrum sativum (coriander) extracts against lead nitrate induced oxidative stress and tissue damage in the liver and kidney in male mice. Int J Appl Biol Pharm 2011;2:65-83.
56. Gurer H, Ozgunes H, Oztezcan S, Ercal N. Antioxidant role of alpha-lipoic acid in lead toxicity. Free Radic Biol Med 1999;27:75-81.
57. Patra RC, Rautray AK, Swarup D. Oxidative stress in lead and cadmium toxicity and its amelioration. Vet Med Int 2011;2011:457327.
58. Pande M, Flora SJ. Lead induced oxidative damage and its response to combined administration of alpha-lipoic acid and succimers in rats. Toxicology 2002;177:187-96.
59. Aykin-Burns N, Laegeler A, Kellogg G, Ercal N. Oxidative effects of lead in young and adult fisher 344 rats. Arch Environ Contam Toxicol 2003;44:417-20.
60. Caylak E, Halifeoiglu I, Aydin S, Telo S, Bulmus O, Celik H. The effects of sulfur-containing compounds on total antioxidant capacity levels of liver, kidney and brain in lead-exposed rats. Turkiye Klinikleri J Med Sci 2007;27:823-8.
61. Flora SJ, Pande M, Mehta A. Beneficial effect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chem Biol Interact 2003;145:267-80.
62. Pande M, Mehta A, Pant BP, Flora SJ. Combined administration of a chelating agent and an antioxidant in the prevention and treatment of acute lead intoxication in rats. Environ Toxicol Pharmacol 2001;9:173 84.
63. Kapoor R, Srivastava S, Kakkar P. Bacopa monnieri modulates antioxidant responses in brain and kidney of diabetic rats. Environ Toxicol Pharmacol 2009;27:62-9.
64. Dreyfus PM. The neurochemistry of vitamin deficiencies. In: Lajtha A, editor. Handbook of Neurochemistry. Vol. 10. New York: Plenum Press; 1985. p. 757-77.
65. Chan AC. Partners in defense, Vitamin E and Vitamin C. Can J Physiol Pharmacol 1993;71:725-31.
66. Leung HW, Vang MJ, Mavis RD. The cooperative interaction between Vitamin E and Vitamin C in suppression of peroxidation of membrane phospholipids. Biochim Biophys Acta 1981;664:266-72.
67. Chaurasia S, Kar A. Protective effects of Vitamin E against lead induced destruction of membrane associated Type-I iodothyronine 5’-monodeiodinase (5’DI) activity in male mice. Toxicology 1997;124:203-9.
68. Anna G, Wiglo S. Antioxidant activity of water soluble vitamins in TEAC (trolox equivalent antioxidant capacity) and the FRAP (Ferric Reducing Antioxidant Power) assays. Food Chem 2006;96:131-6.
69. Cook NC, Samman S. Flavanoids-chemistry, metabolism, cardio protective effects and dietary sources. J Nutr Biochem 1996;7:66-76.
70. Srivastava S, Mishra N, Misra U. Bacopa monnieri a future perspective. Int J Pharm Sci Drug Res 2009;1:154-7.
71. Pawar R, Gopalakrishnan C, Bhutani KK. Dammarane triterpene saponin from Bacopa monniera as the superoxide inhibitor in polymorphonuclear cells. Planta Med 2001;67:752-4.
72. Tripathi YB, Chaurasia S, Tripathi E, Upadhyay A, Dubey GP. Bacopa monniera Linn. As an antioxidant: Mechanism of action. Indian J Exp Biol 1996;34:523-6.
73. Bhattacharya SK, Kumar A, Ghosal S. Effect of Bacopa monniera on animal models of Alzheimer disease and perturbed central cholinergic markers of congnition in rats. In: Sankar DV, editor. Molecular Aspects of Asian Medicines. New York: PJD Publications; 2000.
74. Jyoti A, Sharma D. Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicology 2006;27:451-7.
75. Rameshwari R, Abirami H, Catharin S. Pharmacological actions of Bacopa monnieri: A review. Int J Pharm Ind Res 2013;3:158-67.
76. Sumathi T, Nongbri A. Hepatoprotective effect of bacoside-A, a major constituent of Bacopa monniera Linn. Phytomedicine 2008;15:901-5.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.